Mealey's (March 7, 2023, 12:10 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on March 6 said the Patent Trial and Appeal Board got it right when declaring various claims of a patented phosphoramidate prodrug anticipated by prior art....